EZH2在巨核细胞分化中的双重作用
本研究探讨EZH2在巨核细胞生成中的功能,发现用小分子和短发夹RNA抑制EZH2可加速巨核细胞谱系标志获得而不影响增殖,但在分化后期阻断增殖和多倍体化并减少前血小板形成。在JAK2V617F背景下,EZH2抑制剂同样在体外降低巨核细胞多倍体化和前血小板形成,并在体内降低血小板水平。
要点
- 抑制EZH2加速巨核细胞谱系定向但不改变增殖。
- 分化后期抑制EZH2阻断多倍体化和前血小板形成。
- EZH2通过CDKN1A直接、CDKN2D间接调控多倍体化。
核心结论
- EZH2在巨核细胞分化早期促进谱系定向,在后期促进多倍体化和前血小板形成。
研究设计与样本
- 研究使用小分子和短发夹RNA抑制EZH2,并在JAK2V617F背景下进行体外和体内实验。
主要发现
- EZH2抑制加速巨核细胞谱系标志获得而不改变增殖。
- 分化后期EZH2抑制阻断增殖和多倍体化并减少前血小板形成。
- 在JAK2V617F背景下,EZH2抑制剂在体外降低巨核细胞多倍体化和前血小板形成,在体内降低血小板水平。
- 前血小板形成缺陷与异常肌动蛋白细胞骨架调控通路相关,多倍体化与DNA复制和修复基因表达抑制及CDKN1A和CDKN2D上调相关。
- 敲低CDKN1A和部分敲低CDKN2D可部分挽救多倍体巨核细胞百分比。
关键数值与推荐
- H3K27me3和EZH2染色质免疫沉淀实验显示CDKN1A是EZH2直接靶标,CDKN2D表达不受EZH2直接调控。
临床怎么用
- EZH2抑制剂在JAK2V617F背景下可能降低血小板水平,需关注出血风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
EZH2, the enzymatic component of PRC2, has been identified as a key factor in hematopoiesis. EZH2 loss-of-function mutations have been found in myeloproliferative neoplasms, particularly in myelofibrosis, but the precise function of EZH2 in megakaryopoiesis is not fully delineated. Here, we show that EZH2 inhibition by small molecules and short hairpin RNA induces megakaryocyte (MK) commitment by accelerating lineage marker acquisition without change in proliferation. Later in differentiation, EZH2 inhibition blocks proliferation and polyploidization and decreases proplatelet formation. EZH2 inhibitors similarly reduce MK polyploidization and proplatelet formation in vitro and platelet levels in vivo in a JAK2V617F background. In transcriptome profiling, the defect in proplatelet formation was associated with an aberrant actin cytoskeleton regulation pathway, whereas polyploidization was associated with an inhibition of expression of genes involved in DNA replication and repair and an upregulation of cyclin-dependent kinase inhibitors, particularly CDKN1A and CDKN2D. The knockdown of CDKN1A and to a lesser extent CDKN2D could partially rescue the percentage of polyploid MKs. Moreover, H3K27me3 and EZH2 chromatin immunoprecipitation assays revealed that CDKN1A is a direct EZH2 target and CDKN2D expression is not directly regulated by EZH2, suggesting that EZH2 controls MK polyploidization directly through CDKN1A and indirectly through CDKN2D.
引用
- Mazzi S, Dessen P, Vieira M, et al. Dual role of EZH2 in megakaryocyte differentiation. Blood. 2021. PMID: 34115825. doi:10.1182/blood.2019004638
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。